Rule2024-11811
Advisory Committee; Science Advisory Board to the National Center for Toxicological Research; Termination; Removal From List of Standing Committees
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 30, 2024
Effective
May 30, 2024
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA or Agency) is announcing the termination of the Science Advisory Board to the National Center for Toxicological Research (NCTR). This document announces the reasons for termination and removes the Science Advisory Board to the NCTR from the Agency's list of standing advisory committees.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 105 (Thursday, May 30, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 105 (Thursday, May 30, 2024)]
[Rules and Regulations]
[Page 46802]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-11811]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 14
[Docket No. FDA-2024-N-2357]
Advisory Committee; Science Advisory Board to the National Center
for Toxicological Research; Termination; Removal From List of Standing
Committees
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
the termination of the Science Advisory Board to the National Center
for Toxicological Research (NCTR). This document announces the reasons
for termination and removes the Science Advisory Board to the NCTR from
the Agency's list of standing advisory committees.
DATES: This rule is effective May 30, 2024.
FOR FURTHER INFORMATION CONTACT: Ashley Groves, Designated Federal
Officer, National Center for Toxicological Research, Food and Drug
Administration, 3900 NCTR Rd., 50-719, Jefferson, AR 72079, 870-543-
7956, <a href="/cdn-cgi/l/email-protection#f6b7859e9a938fd8b18499809385b6909297d89e9e85d8919980"><span class="__cf_email__" data-cfemail="eeaf9d86828b97c0a99c81988b9dae888a8fc086869dc0898198">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The Science Advisory Board to the National
Center for Toxicological Research (the Committee) was established on
June 2, 1973 (38 FR 18478). The Committee advises the Commissioner of
Food and Drugs or designee in discharging responsibilities as they
relate to helping to ensure safe and effective drugs for human use and
as required, any other product for which FDA has regulatory
responsibility.
The Committee is no longer needed and will be terminated on June 2,
2024. Over the past several years, the Committee has met very
infrequently, and the effort and expense of maintaining the Committee
are no longer justified. The Science Board to FDA (Science Board)
provides advice to the Commissioner and other appropriate officials on
specific complex scientific and technical issues important to FDA and
its mission, including emerging issues within the scientific community.
Additionally, the Committee provides advice that supports the Agency in
keeping pace with technical and scientific developments, including in
regulatory science; and input into the Agency's research agenda; and on
upgrading its scientific and research facilities and training
opportunities. It also provides, where requested, expert review of
Agency-sponsored intramural and extramural scientific research
programs. In the future, any issues on which NCTR requires expert
advice will be addressed by utilizing the Science Board with additional
augmentation of expertise by appropriate subject matter experts serving
as temporary members on that committee.
Under 5 U.S.C. 553(b)(3)(B) and (d) and 21 CFR 10.40(d) and (e),
the Agency finds good cause to dispense with notice and public comment
procedures and to proceed to an immediate effective date on this rule.
Notice and public comment and a delayed effective date are
unnecessary because the Committee is not being adequately used, and
termination of the committee is effective on June 2, 2024, in
accordance with 21 CFR 14.55. This final rule merely removes the name
of the Science Advisory Board to the National Center for Toxicological
Research from the list of standing advisory committees in Sec. 14.100
(21 CFR 14.100).
Therefore, the Agency is amending Sec. 14.100(e) as set forth in
the regulatory text of the document.
List of Subjects in 21 CFR Part 14
Administrative practice and procedure, Advisory committee, Color
additives, Drugs, Radiation protection.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs, 21 CFR part
14 is amended as follows:
PART 14--PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE
0
1. The authority citation for part 14 continues to read as follows:
Authority: 5 U.S.C. 1001 et seq.; 15 U.S.C. 1451-1461; 21 U.S.C.
41-50, 141-149, 321-394, 467f, 679, 821, 1034; 28 U.S.C. 2112; 42
U.S.C. 201, 262, 263b, 264, 284m, 284m-1; Pub. L. 107-109, 115 Stat.
1419.
Sec. 14.100 [Amended]
0
2. Amend Sec. 14.100 by removing paragraph (e).
Dated: May 23, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-11811 Filed 5-29-24; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 30, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.